Low Dose Dexmedetomidine as a Postoperative Pain Adjunct
Key facts
- Who runs it
- Nichole Doyle
- Where
- Kansas City, United StatesSee the site
- Trial code
- Status
- Enrolling by invitation
- Phase
- Phase 2
- People taking part
- 46 people, planned
- Started
- 1 Jul 2024
- Expected to end
- Jul 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Dexmedetomidine
- Normal Saline
- Record updated
- 5 October 2026
Who can take part
- Age
- 10 years to 21 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Diagnosis of idiopathic scoliosis
- Undergoing a posterior spinal fusion of at least 5 levels with both thoracic and lumbar involvement
Who cannot take part
- Patients with a history of chronic pain currently taking opioids, TCA's, Gabapentinoids
- Known allergy to dexmedetomidine or any of the standard medications used intra or post operatively
- Moya Moya disease
- Medical contraindications to administration of dexmedetomidine, unstable cardiac status, (prolonged Qtc, life threatening arrhythmias, use of digoxin)
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 10 and 21 years old?
Where in United States
- Children's Mercy HospitalKansas City, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
This randomized controlled trial examines whether the addition of a low-dose dexmedetomidine infusion to our current multimodal pain management plan decreases narcotic consumption and reduces side effects in adolescent patients undergoing posterior spinal fusion for idiopathic scoliosis.
The 2 groups in the trial
- DexmedetomidineTreatment being tested
Patient receives low dose dexmedetomidine infusion in addition to normal post-operative pain management protocol
- ControlPlacebo, for comparison
Patient receives normal saline infusion in addition to normal post-operative pain management protocol
Treatment: Normal Saline
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Dexmedetomidine as a Pain Management Adjunct in the Pediatric Population Undergoing Posterior Spinal Fusion
- Criteria questions
- Built from NCT06067893, who can take part
- Record updated
- 5 October 2026